Our aim is to deliver "Better quality of life!"
Otsuka Pharma Scandinavia AB was established in Stockholm October 2001, for the Scandinavian market.
The company is a part of the Otsuka Pharmaceuticals group. The European head office, Otsuka Pharmaceutical Europe Ltd. is located in London. Otsuka Pharmaceutical Co. Ltd, that is one of the largest healthcare companies in Japan heads the Otsuka Pharmaceutical group.
The Nordic and Baltic markets comprise of a team of 15 individuals currently focusing on launching our new product for the Intermittent claudication and continue marketing and sales of Adacolumn®.
“Abilify®”, one of our pharmaceutical products, is marketed by Bristol Myer Squibb in the Nordic markets.